Skip to main content

Tempest Therapeutics, Inc.

TPST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001544227

No open-market purchases or sales by Tempest Therapeutics, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.44M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Tempest Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of TPST: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders2835+7
Shares2.83M6.78M+3.95M (+139.6%)
Value$3.94M$5.66M+$1.71M (+43.5%)

New holders (14)

Institutions that held Tempest Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to TPST in Q4 2024
InstitutionSharesValue% of portfolio
Versant Venture Management, LLC3,507,055$2.93M3.37%
Jane Street Group, LLC493,094$411.5K0.00%
Millennium Management LLC189,506$158.1K0.00%
Virtu Financial LLC43,105$36.0K0.00%
Engineers Gate Manager LP23,496$19.6K0.00%
National Bank of Canada10,000$8.35K0.00%
Federation des caisses Desjardins du Quebec3,800$3.17K0.00%
Citigroup Inc972$8110.00%
Millstone Evans Group, LLC800$6680.00%
SBI Securities Co., Ltd.767$6400.00%
R Squared Ltd190$1590.00%
BNP Paribas Arbitrage, SA48$400.00%
Global Retirement Partners, LLC5$40.00%
Royal Bank of Canada1$00.00%

Sold out (7)

Institutions that held Tempest Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of TPST in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Altium Capital Management LP545,000$763.0K
Gsa Capital Partners LLP94,912$133.0K
Fullcircle Wealth LLC62,000$68.2K
Empower Advisory Group, LLC35,000$49.0K
Tocqueville Asset Management L.P.32,750$45.9K
Two Sigma Investments, LP22,921$32.1K
Ground Swell Capital, LLC10,896$15.3K